ArticleScientific reports2025
Perirenal fat thickness may be a significant predictor of prognosis and postoperative renal function in renal cancer surgery patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Study on the prediction of postoperative metastasis in renal cancer using perirenal fat CT radiomics combined with clinical features.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Renal cell carcinoma accounts for a significant number of kidney malignancy-related fatalities globally. Perirenal Fat Thickness (PRFT) may indicate a state of nutritional excess in patients, which is potentially directly linked to both the incidence and prognosis of kidney cancer. This study investigated the association between perirenal fat thickness (PRFT) and overall survival (OS), as well as the predictive value of PRFT for postoperative estimated glomerular filtration rate (eGFR) in patients with renal cell carcinoma (RCC). A retrospective cohort of 1647 RCC patients from 2014 to 2021 was analyzed, divided into radical nephrectomy (RN) and partial nephrectomy (PN) groups. Preoperative measurements included visceral fat area, PRFT, and subcutaneous fat area. Kaplan-Meier curves compared OS between high and low PRFT groups, while Cox regression analyses identified prognostic factors for OS, and linear regression analyses assessed predictors of postoperative eGFR. PRFT significantly influenced OS in RN patients in univariate analysis (HR: 0.32; 95% CI: 0.19-0.52; P < 0.001), but not in PN patients. After adjusting for covariates such as age, sex, sarcomatoid features, necrosis, T stage, Fuhrman grade, smoking status, subcutaneous adipose tissue, and BMI, PRFT remained an independent risk factor for OS (HR: 0.56; 95% CI: 0.33-0.96; P < 0.001). Kaplan-Meier analysis showed that higher PRFT was associated with improved OS in RN patients. Univariate linear regression revealed that high PRFT correlated with reduced postoperative eGFR in both RN (β = -0.2, P = 0.002) and PN (β = -0.34, P < 0.001) groups; however, this correlation was not significant after multivariate adjustment. In conclusion, Low PRFT is independently associated with higher mortality in RCC patients undergoing RN. High PRFT is associated with reduced postoperative eGFR in initial analyses, but this association was not significant in multivariate analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.